UX-GIP001 cell therapy for drug-resistant temporal lobe epilepsy
Part of Brain & nervous system clinical trials.
This trial tests a new cell therapy, UX-GIP001, for people whose seizures start in one small area of the brain (the mesial temporal lobe) and are not controlled by at least two seizure medications. The goal is to see if this treatment can safely reduce seizures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your seizures start from one specific area deep inside the temporal lobe (mesial temporal lobe epilepsy).
- You have tried at least two seizure medications at high enough doses, but seizures still happen.
- You have had at least 4 focal (partial) seizures per month on average over the past 3 months.
- You have been on the same doses of your seizure meds for at least the last month.
- You have no other major health problems (such as a severe immune disorder or recent cancer) and do not have metal implants in your skull or brain.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests whether transplanting special cells (UX-GIP001) into the brain can reduce seizures in people with drug-resistant epilepsy affecting the mesial temporal lobe—a common seizure origin that doesn't respond well to medications. The goal is to evaluate safety and whether this approach helps control seizures.
This trial tests a type of brain stimulation therapy (TIS) for people with temporal lobe epilepsy that hasn't responded well to seizure medications. The goal is to help reduce how often seizures happen.
This study tests a procedure that uses tiny electrodes to find and treat the area of the brain causing seizures in people with a specific type of epilepsy that does not get better with medication.
This study tests a non-invasive focused ultrasound treatment for people with epilepsy that doesn't respond to medications. The goal is to see if this gentle ultrasound can reduce seizures without surgery.
This trial uses detailed brain tests to better match people with epilepsy to the right treatment. It may help by using “precision medicine” methods to understand what in the brain is driving seizures.
This trial tests a new type of stimulation placed under the skin to help control seizures in people with epilepsy. It is for patients whose seizures are not controlled with medication and who cannot have surgery.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.